Proficio Capital Partners LLC acquired a new stake in shares of MannKind Co. (NASDAQ:MNKD – Free Report) in the fourth ...

MannKind’s stock has fluctuated due to Tyvaso DPI’s Q4 underperformance and competitive pressures, but it remains a key revenue driver for future profitability and R&D funding. Tyvaso DPI’s ...

Before you buy stock in MannKind, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and MannKind wasn ...

Shares of Mannkind (NASDAQ:MNKD) rose 7% in post-market trading Wednesday after the company issued its Q4 earnings report and a business update. Mannkind (NASDAQ:MNKD) reported a Q4 net profit of ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sarepta Therapeutics (SRPT – Research Report), ...

Investors eyeing a purchase of MannKind Corp (Symbol: MNKD) stock, but tentative about paying the going market price of $4.96/share, might benefit from considering selling puts among the ...

EST MannKind (MNKD) files automatic mixed securities shelfDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

DANBURY, Conn. (AP) — DANBURY, Conn. (AP) — MannKind Corp. (MNKD) on Wednesday reported net income of $7.4 million in its fourth quarter. The Danbury, Connecticut-based company said it had net ...